Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Veterinary Animal Vaccines market in this environment.
In terms of revenue, this research report indicated that the global Veterinary Animal Vaccines market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Veterinary Animal Vaccines industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Zoetis Inc. (Pfizer) aims at producing XX Veterinary Animal Vaccines in 2020, with XX % production to take place in global market, ? ? ? ? Merck Animal Health accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Veterinary Animal Vaccines Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Veterinary Animal Vaccines Market?
Zoetis Inc. (Pfizer)
Merck Animal Health
Merial Inc.
Boehringer Ingelheim
Bayer Animal Health
Elanco Animal Health
Ceva Animal Health
Heska Corporation
Virbac Inc.
...
Major Type of Veterinary Animal Vaccines Covered in XYZResearch report:
Livestock Diseases
Porcine Diseases
Poultry Diseases
Companion Animal Diseases
Equine Diseases
Aquaculture Diseases
Other
Application Segments Covered in XYZResearch Market
Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Conjugate Vaccines
DNA Vaccines
Recombinant Vaccines
Subunit Vaccines
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Veterinary Animal Vaccines Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Livestock Diseases -Product Introduction and Major Manufacturers
1.1.2 Porcine Diseases -Product Introduction and Major Manufacturers
1.1.3 Poultry Diseases -Product Introduction and Major Manufacturers
1.1.4 Companion Animal Diseases -Product Introduction and Major Manufacturers
1.1.5 Equine Diseases -Product Introduction and Major Manufacturers
1.1.6 Aquaculture Diseases -Product Introduction and Major Manufacturers
1.1.7 Other -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Veterinary Animal Vaccines Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Veterinary Animal Vaccines Market
3.1.1 Top Companies leading Veterinary Animal Vaccines Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Veterinary Animal Vaccines Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Veterinary Animal Vaccines Market
3.2.1 Top Companies leading Veterinary Animal Vaccines Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Veterinary Animal Vaccines Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Veterinary Animal Vaccines Market
3.3.1 Top Companies leading Veterinary Animal Vaccines Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Veterinary Animal Vaccines Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Veterinary Animal Vaccines Market
3.4.1 Top Companies leading Veterinary Animal Vaccines Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Veterinary Animal Vaccines Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Veterinary Animal Vaccines Market
3.5.1 Top Companies leading Veterinary Animal Vaccines Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Veterinary Animal Vaccines Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Veterinary Animal Vaccines Market
3.6.1 Top Companies leading Veterinary Animal Vaccines Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Veterinary Animal Vaccines Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Veterinary Animal Vaccines Market
3.7.1 Top Companies leading Veterinary Animal Vaccines Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Veterinary Animal Vaccines Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Veterinary Animal Vaccines Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Veterinary Animal Vaccines Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Veterinary Animal Vaccines Sales and Growth Rate (2021-2026)
5.2 Global Veterinary Animal Vaccines Sales Value and Growth Rate (2021-2026)
6 Veterinary Animal Vaccines Competitive Analysis
6.1 Zoetis Inc. (Pfizer)
6.1.1 Zoetis Inc. (Pfizer) Company Profiles
6.1.2 Zoetis Inc. (Pfizer) Product Introduction
6.1.3 Zoetis Inc. (Pfizer) Veterinary Animal Vaccines Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Profiles
6.2.2 Merck Animal Health Product Introduction
6.2.3 Merck Animal Health Veterinary Animal Vaccines Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Merial Inc.
6.3.1 Merial Inc. Company Profiles
6.3.2 Merial Inc. Product Introduction
6.3.3 Merial Inc. Veterinary Animal Vaccines Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Profiles
6.4.2 Boehringer Ingelheim Product Introduction
6.4.3 Boehringer Ingelheim Veterinary Animal Vaccines Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Bayer Animal Health
6.5.1 Bayer Animal Health Company Profiles
6.5.2 Bayer Animal Health Product Introduction
6.5.3 Bayer Animal Health Veterinary Animal Vaccines Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Elanco Animal Health
6.6.1 Elanco Animal Health Company Profiles
6.6.2 Elanco Animal Health Product Introduction
6.6.3 Elanco Animal Health Veterinary Animal Vaccines Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Ceva Animal Health
6.7.1 Ceva Animal Health Company Profiles
6.7.2 Ceva Animal Health Product Introduction
6.7.3 Ceva Animal Health Veterinary Animal Vaccines Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Heska Corporation
6.8.1 Heska Corporation Company Profiles
6.8.2 Heska Corporation Product Introduction
6.8.3 Heska Corporation Veterinary Animal Vaccines Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Virbac Inc.
6.9.1 Virbac Inc. Company Profiles
6.9.2 Virbac Inc. Product Introduction
6.9.3 Virbac Inc. Veterinary Animal Vaccines Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
7 Conclusion
The Animal Model Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
Market Overview
The Asia Pacific Functional Proteins Market is projected to experience robust growth from 2024 to 2034, driven by increasing consumer awareness of health and wellness, along with the expanding applications of functional proteins across various industries. The market is e...
Market Overview
The Europe Functional Proteins Market is anticipated to witness significant growth from 2024 to 2034, driven by increasing health consciousness, rising demand for protein-enriched products, and expanding applications in the food and beverage industry. The market is proje...
Market Overview
The North America Functional Proteins Market is anticipated to witness substantial growth from 2024 to 2034, driven by the increasing consumer demand for health and wellness products, rising applications in food and dietary supplements, and advancements in protein extrac...
Market Overview
The Global Functional Proteins Market is anticipated to witness substantial growth over the next decade, driven by increasing consumer awareness of health and wellness, the rising demand for protein-rich diets, and expanding applications across various industries. As of ...
The Animal Gut Health Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Non-animal-sourced Alternative Proteins Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Veterinary Digital Pathology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Companion Animal Diagnostics Imaging Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Animal Regenerative Medicine and Stem Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competi...